Ampio Pharmaceuticals (AMPE) Stock Price, News & Analysis

Company Overview

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.

Key Stats

• Today's Range: $0.0027 to $0.0027
• 50-Day Range: $0.00 to $0.13
• 52-Week Range: $0.00 to $0.45
• Volume: 279 shs
• Average Volume: 615 shs
• Market Capitalization: $3.06 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Ampio Pharmaceuticals Stock Analysis - MarketRank™

Ampio Pharmaceuticals scored higher than 3% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Ampio Pharmaceuticals.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Ampio Pharmaceuticals is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Ampio Pharmaceuticals is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Ampio Pharmaceuticals has a P/B Ratio of 0.00. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.01% of the float of Ampio Pharmaceuticals has been sold short.

Short Interest Ratio / Days to Cover

Ampio Pharmaceuticals has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Ampio Pharmaceuticals does not currently pay a dividend.

Dividend Growth

Ampio Pharmaceuticals does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.01% of the float of Ampio Pharmaceuticals has been sold short.

Short Interest Ratio / Days to Cover

Ampio Pharmaceuticals has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

Search Interest

Only 1 people have searched for AMPE on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Ampio Pharmaceuticals insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 3.30% of the stock of Ampio Pharmaceuticals is held by insiders.

Percentage Held by Institutions

Only 5.73% of the stock of Ampio Pharmaceuticals is held by institutions.

AMPE Stock Analysis - Frequently Asked Questions

How have AMPE shares performed this year?

Ampio Pharmaceuticals' stock was trading at $0.0026 at the beginning of 2025. Since then, AMPE stock has increased by 3.8% and is now trading at $0.0027.
View the best growth stocks for 2025 here.

How were Ampio Pharmaceuticals' earnings last quarter?

Ampio Pharmaceuticals, Inc. (NYSE:AMPE) released its quarterly earnings data on Wednesday, November, 10th. The company reported ($0.40) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.40).

When did Ampio Pharmaceuticals' stock split?

Ampio Pharmaceuticals's stock reverse split on the morning of Tuesday, September 12th 2023. The 1-20 reverse split was announced on Thursday, August 31st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, September 11th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

How do I buy shares of Ampio Pharmaceuticals?

Shares of AMPE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Ampio Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Ampio Pharmaceuticals investors own include Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), CymaBay Therapeutics (CBAY), Trevena (TRVN), GE Aerospace (GE) and Catalyst Pharmaceuticals (CPRX).

Company Calendar

• Last Earnings: 11/10/2021
• Today: 6/21/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NYSE:AMPE
• CIK: 1411906
• Web: ampiopharma.com
• Phone: 720-437-6500
• Fax: 720-437-6501
• Employees: 20
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $4.04 per share
• Price / Book: 0.00

Miscellaneous

• Outstanding Shares: 1,135,000
• Free Float: 1,098,000
• Market Cap: $3.06 thousand
• Optionable: No Data
• Beta: 4.92